Search
Read about Sandy Freiberg, who ran a marathon to honor his brother, Evan, who is in his fifth year of cancer treatment at Memorial Sloan Kettering.
A study that shows lung cancer risk varies widely among smokers may help individuals and their doctors decide if voluntary screening is appropriate for them.
MSK award recognizes promising investigators for their efforts in advancing cancer research.
A collaborative effort among cancer experts from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College has yielded an interesting association: Obesity prior to diagnosis is associated with a five-fold increase in the risk of death from early-stage squamous cell carcinoma of the tongue.
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
A new study by researchers at Memorial Sloan Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.
A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.
By uncovering the root cause of cytokine release syndrome, MSK researchers have found a way to stop it.
Fourth-year student Yvonne Gruber was awarded a $10,000 melanoma research grant by the Joanna M. Nicolay Melanoma Foundation.
Gerstner Sloan Kettering welcomed its sixth class of PhD students on July 25, 2011. The incoming class is composed of three women and seven men.